TBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Telesis Bio's change in inventory for the quarter that ended in Jun. 2024 was $0.26 Mil. It means Telesis Bio's inventory declined by $0.26 Mil from Mar. 2024 to Jun. 2024 .
Telesis Bio's change in inventory for the fiscal year that ended in Dec. 2023 was $-1.83 Mil. It means Telesis Bio's inventory increased by $1.83 Mil from Dec. 2022 to Dec. 2023 .
Telesis Bio's Total Inventories for the quarter that ended in Jun. 2024 was $1.36 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Telesis Bio's Days Inventory for the quarter that ended in Jun. 2024 was 97.62.
Inventory Turnover measures how fast the company turns over its inventory within a year. Telesis Bio's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Telesis Bio's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 1.62.
The historical data trend for Telesis Bio's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Change In Inventory | - | 0.11 | -1.46 | 0.17 | -1.83 |
Telesis Bio Quarterly Data | |||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Change In Inventory | Get a 7-Day Free Trial | -1.62 | -0.36 | 0.25 | 0.36 | 0.26 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio (NAS:TBIO) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Telesis Bio's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 2.513 | / | 2.349 | * | 365 / 4 | |
= | 97.62 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Telesis Bio's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 2.349 | / | 2.513 | |
= | 0.93 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Telesis Bio's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 2.513 | / | 1.55 | |
= | 1.62 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Telesis Bio's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Gregory J. Herrema | director | 355 RIVER OAKS PARKWAY, SAN JOSE CA 95134 |
Marijn E Dekkers | 10 percent owner | GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210 |
Novalis Lifesciences Investments Ii Gp, Llc | 10 percent owner | 1 LIBERTY LANE E, SUITE 112, HAMPTON NH 03842 |
Novalis Lifesciences Investments Ii, L.p. | 10 percent owner | 1 LIBERTY LANE E, SUITE 112, HAMPTON NH 03842 |
Broadoak Fund Iv, Llc | 10 percent owner | 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814 |
William Snider | director, 10 percent owner | 4800 MONTGOMERY LANE, SUITE 230, BETHESDA MD 20814 |
Paul M Meister | director, 10 percent owner | 18 SHIP ROCK ROAD, NORTH HAMPTON NH 03862 |
Rob Cutler | officer: Chief Legal Officer | C/O TELESIS BIO, INC., 9535 WAPLES STREET, SUITE 100, SAN DIEGO CA 92121 |
Daniel Glenn Gibson | officer: Chief Technology Officer | C/O CODEX DNA, INC., 9535 WAPLES STREET, SUITE 100, SAN DIEGO CA 92121 |
Todd Robert Nelson | director, 10 percent owner, officer: President & CEO | C/O CODEX DNA, INC., 9535 WAPLES STREET, SUITE 100, SAN DIEGO CA 92121 |
Eric Eugene Esser | officer: Chief Operating Officer | C/O CODEX DNA, INC., 9535 WAPLES STREET, SUITE 100, SAN DIEGO CA 92121 |
Annette Tumolo | director | C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547 |
Northpond Ventures Gp, Llc | 10 percent owner | 7500 OLD GEORGETOWN ROAD, SUITE 850, BETHESDA MD 20814 |
Northpond Ventures Gp Ii, Llc | 10 percent owner | 7500 OLD GEORGETOWN ROAD, SUITE 850, BESTHESDA MD 20814 |
Northpond Ventures Ii, Lp | 10 percent owner | 7500 OLD GEORGETOWN ROAD, SUITE 850, BETHESDA MD 20814 |
From GuruFocus
By sperokesalga sperokesalga • 05-18-2023
By PurpleRose PurpleRose • 08-02-2022
By sperokesalga sperokesalga • 03-21-2023
By Value_Insider Value_Insider • 11-02-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By sperokesalga sperokesalga • 03-31-2023
By sperokesalga sperokesalga • 06-05-2023
By sperokesalga sperokesalga • 02-27-2023
By sperokesalga sperokesalga • 05-23-2023
By PurpleRose PurpleRose • 07-12-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.